Table 1.
URF no.a | Patient IDb | Sexc | Origin | Parental strains | Exposure categoryd | City (region) of sampling | Yr of sampling |
---|---|---|---|---|---|---|---|
1 | 21 | F | Eastern Europe | B/A1 | IDU | Granada (East Andalusia) | 2005 |
2 | 41 | M | Eastern Europe | A1/B | IDU | Elche (Valencia) | 2008 |
3 | 46 | M | Equatorial Guinea | B/CRF02 | Heterosex. | Madrid | 2007 |
4 | 52 | M | Equatorial Guinea | B/CRF02 | Heterosex. | Madrid | 2005 |
5 | 29 | F | North Africa | B/CRF02 | Heterosex. | Madrid | 2005 |
6 | 50 | M | Spain | B/CRF02 | Homosex. | Malaga (South Andalusia) | 2008 |
7 | 1 | U | Spain | B/F1 | Heterosex. | Seville (West Andalusia) | 2008 |
8 | 76 | M | Spain | B/F1 | Homosex. | Madrid | 2006 |
9 | 39 | M | South America | CRF02/B | Other | Madrid | 2006 |
10 | 34 | M | Spain | B/C | Heterosex. | Madrid | 2008 |
11 | 66 | F | Sub-Saharan Africa | J/C/A1/K | Heterosex. | Terrassa (Catalonia) | 2008 |
Numbered as in Fig. 1.
Patient number according to the sequence alignment provided as File S1 in the supplemental material.
M, male; F, female; U, unknown.
Heterosex., heterosexual risk behavior; Homosex., homo/bisexual risk behavior; IDU, injecting drug user.